M
Motohiro Takeya
Researcher at Kumamoto University
Publications - 114
Citations - 7479
Motohiro Takeya is an academic researcher from Kumamoto University. The author has contributed to research in topics: Macrophage & Cancer. The author has an hindex of 43, co-authored 114 publications receiving 6248 citations.
Papers
More filters
Journal ArticleDOI
Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
TL;DR: It is suggested that tumour‐derived M‐CSF induces a shift of microglia/macrophages towards the M2 phenotype, which influences tumour growth.
Journal ArticleDOI
Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy.
TL;DR: The macrophage is known to be a multifunctional antigen presenting cells and playing a central role in inflammation, and infiltrating TAMs themselves or polarization pathway of TAMs are considered as new therapeutic targets for the therapy of malignant tumors.
Journal ArticleDOI
Clinical significance of macrophage heterogeneity in human malignant tumors
TL;DR: The role of TAMs in human malignant tumors and the cell–cell interactions between TAMs and tumor cells are discussed.
Journal ArticleDOI
A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Junichi Matsubara,Seigo Sugiyama,Koichi Sugamura,Taishi Nakamura,Yukio Fujiwara,Eiichi Akiyama,Hirofumi Kurokawa,Toshimitsu Nozaki,Keisuke Ohba,Masaaki Konishi,Hirofumi Maeda,Yasuhiro Izumiya,Koichi Kaikita,Hitoshi Sumida,Hideaki Jinnouchi,Kunihiko Matsui,Shokei Kim-Mitsuyama,Motohiro Takeya,Hisao Ogawa +18 more
TL;DR: A DPP-4 inhibitor, DFS, exhibited antiatherogenic effects through augmenting GLP-1 activity in macrophages and endothelium, and sustained endothelial nitric oxide synthase phosphorylation and decreased endothelial senescence and apoptosis compared with GLp-1 alone.
Journal ArticleDOI
Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
Horlad Hasita,Yoshihiro Komohara,Hirohisa Okabe,Toshiro Masuda,Koji Ohnishi,Xiao F. Lei,Toru Beppu,Hideo Baba,Motohiro Takeya +8 more
TL;DR: Analysis of macrophage populations and phenotypes in intrahepatic cholangiocarcinoma patients provides suggestive evidence that TAMs contribute to cancer progression via Stat3 activation, and CD163 is useful for evaluating M2 TAMs and predicting the clinical prognosis of ICC patients.